These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 12214161)

  • 41. A new candidate mutation, G1629R, in a patient with type 2A von Willebrand's disease: basic mechanisms and clinical implications.
    Hilbert L; Federici AB; Baronciani L; Dallagiovanna S; Mazurier C
    Haematologica; 2004 Sep; 89(9):1128-33. PubMed ID: 15377475
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome.
    Luboshitz J; Lubetsky A; Schliamser L; Kotler A; Tamarin I; Inbal A
    Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acquired von Willebrand syndrome in patients with monoclonal gammopathy of undetermined significance investigated using a mechanistic approach.
    Galletta E; Galvanin F; Bertomoro A; Daidone V; Casonato A
    Blood Transfus; 2023 Jan; 21(1):74-82. PubMed ID: 34694218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Changes in ADAMTS13 (von-Willebrand-factor-cleaving protease) activity after induced release of von Willebrand factor during acute systemic inflammation.
    Reiter RA; Varadi K; Turecek PL; Jilma B; Knöbl P
    Thromb Haemost; 2005 Mar; 93(3):554-8. PubMed ID: 15735809
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
    Ishimaru F; Hayashi H; Fujita T; Tsurumi N; Tsuda T; Kimura I
    Rinsho Ketsueki; 1990 Sep; 31(9):1493-8. PubMed ID: 2246822
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Assay of von Willebrand factor (vWF)-cleaving protease based on decreased collagen binding affinity of degraded vWF: a tool for the diagnosis of thrombotic thrombocytopenic purpura (TTP).
    Gerritsen HE; Turecek PL; Schwarz HP; Lämmle B; Furlan M
    Thromb Haemost; 1999 Nov; 82(5):1386-9. PubMed ID: 10595623
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Association of acquired von Willebrand syndrome with AL amyloidosis.
    Kos CA; Ward JE; Malek K; Sanchorawala V; Wright DG; O'Hara C; Connors L; Skinner M; Seldin DC
    Am J Hematol; 2007 May; 82(5):363-7. PubMed ID: 17205535
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Altered von Willebrand factor subunit proteolysis and multimer processing associated with the Cys2362Phe mutation in the B2 domain.
    Casonato A; De Marco L; Gallinaro L; Sztukowska M; Mazzuccato M; Battiston M; Pagnan A; Ruggeri ZM
    Thromb Haemost; 2007 Apr; 97(4):527-33. PubMed ID: 17393013
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Reduced larger von Willebrand factor multimers at dawn in OSA plasmas reflect severity of apnoeic episodes.
    Koyama N; Matsumoto M; Tamaki S; Yoshikawa M; Fujimura Y; Kimura H
    Eur Respir J; 2012 Sep; 40(3):657-64. PubMed ID: 22362856
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Acquired von Willebrand syndrome in three patients and literature review].
    Ouyang HY; Yu ZJ; Yin J; Zhao XJ; Wang ZY; Zhang W; Ma ZN; Su J; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):692-5. PubMed ID: 27587252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acquired von Willebrand syndrome: features and management.
    Mohri H
    Am J Hematol; 2006 Aug; 81(8):616-23. PubMed ID: 16823821
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Acquired von Willebrand syndrome with autoimmune hemolytic anemia].
    Sakai M; Shima M; Izumi Y; Shirahata A
    Rinsho Ketsueki; 2004 Mar; 45(3):223-7. PubMed ID: 15103936
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Deficient activity of von Willebrand's factor-cleaving protease in patients with disseminated malignancies.
    Oleksowicz L; Bhagwati N; DeLeon-Fernandez M
    Cancer Res; 1999 May; 59(9):2244-50. PubMed ID: 10232615
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance.
    Ojeda-Uribe M; Caron C; Itzhar-Baikian N; Debliquis A
    Am J Hematol; 2010 May; 85(5):396. PubMed ID: 20425807
    [No Abstract]   [Full Text] [Related]  

  • 55. Acquired von Willebrand's disease: a concise review.
    Rinder MR; Richard RE; Rinder HM
    Am J Hematol; 1997 Feb; 54(2):139-45. PubMed ID: 9034288
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Acquired von Willebrand's syndrome in association with a lupus-like anticoagulant corrected by intravenous immunoglobulin.
    Hanley D; Arkel YS; Lynch J; Kamiyama M
    Am J Hematol; 1994 Jun; 46(2):141-6. PubMed ID: 8172182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survival of von Willebrand factor released following DDAVP in a type 1 von Willebrand disease cohort: influence of glycosylation, proteolysis and gene mutations.
    Millar CM; Riddell AF; Brown SA; Starke R; Mackie I; Bowen DJ; Jenkins PV; van Mourik JA
    Thromb Haemost; 2008 May; 99(5):916-24. PubMed ID: 18449422
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Von Willebrand factor and ADAMTS13 balancing primary haemostasis].
    Schneppenheim R; Budde U
    Hamostaseologie; 2011 Nov; 31(4):275-80. PubMed ID: 21792464
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.
    Koyama T; Fujimoto K; Shima M
    Intern Med; 2013; 52(23):2661-3. PubMed ID: 24292759
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guidelines for the evaluation of intravenous desmopressin and von Willebrand factor/factor VIII concentrate in the treatment and prophylaxis of bleedings in von Willebrand disease types 1, 2, and 3.
    Michiels JJ; Gadisseur A; van der Planken M; Schroyens W; van de Velden A; Berneman Z
    Semin Thromb Hemost; 2006 Sep; 32(6):636-45. PubMed ID: 16977574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.